Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.G.Bochukova,
T.Roscioli,
D.J.Hedges,
I.B.Taylor,
D.Johnson,
D.J.David,
P.L.Deininger,
and
A.O.Wilkie
(2009).
Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily.
|
| |
Hum Mutat, 30,
204-211.
|
 |
|
|
|
|
 |
E.Stuttfeld,
and
K.Ballmer-Hofer
(2009).
Structure and function of VEGF receptors.
|
| |
IUBMB Life, 61,
915-922.
|
 |
|
|
|
|
 |
M.Zakrzewska,
A.Wiedlocha,
A.Szlachcic,
D.Krowarsch,
J.Otlewski,
and
S.Olsnes
(2009).
Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.
|
| |
J Biol Chem, 284,
25388-25403.
|
 |
|
|
|
|
 |
S.Li,
C.Christensen,
L.B.Køhler,
V.V.Kiselyov,
V.Berezin,
and
E.Bock
(2009).
Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons.
|
| |
Dev Neurobiol, 69,
837-854.
|
 |
|
|
|
|
 |
A.R.Grosso,
S.Martins,
and
M.Carmo-Fonseca
(2008).
The emerging role of splicing factors in cancer.
|
| |
EMBO Rep, 9,
1087-1093.
|
 |
|
|
|
|
 |
K.Chen,
Y.Ohkubo,
D.Shin,
T.Doetschman,
L.P.Sanford,
H.Li,
and
F.M.Vaccarino
(2008).
Decrease in excitatory neurons, astrocytes and proliferating progenitors in the cerebral cortex of mice lacking exon 3 from the Fgf2 gene.
|
| |
BMC Neurosci, 9,
94.
|
 |
|
|
|
|
 |
S.B.Joshi,
T.J.Kamerzell,
C.McNown,
and
C.R.Middaugh
(2008).
The interaction of heparin/polyanions with bovine, porcine, and human growth hormone.
|
| |
J Pharm Sci, 97,
1368-1385.
|
 |
|
|
|
|
 |
S.Mori,
C.Y.Wu,
S.Yamaji,
J.Saegusa,
B.Shi,
Z.Ma,
Y.Kuwabara,
K.S.Lam,
R.R.Isseroff,
Y.K.Takada,
and
Y.Takada
(2008).
Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.
|
| |
J Biol Chem, 283,
18066-18075.
|
 |
|
|
|
|
 |
S.Oltean,
P.G.Febbo,
and
M.A.Garcia-Blanco
(2008).
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
|
| |
Clin Exp Metastasis, 25,
611-619.
|
 |
|
|
|
|
 |
H.Kurosu,
M.Choi,
Y.Ogawa,
A.S.Dickson,
R.Goetz,
A.V.Eliseenkova,
M.Mohammadi,
K.P.Rosenblatt,
S.A.Kliewer,
and
M.Kuro-o
(2007).
Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
|
| |
J Biol Chem, 282,
26687-26695.
|
 |
|
|
|
|
 |
I.Mason
(2007).
Initiation to end point: the multiple roles of fibroblast growth factors in neural development.
|
| |
Nat Rev Neurosci, 8,
583-596.
|
 |
|
|
|
|
 |
N.Kulahin,
V.Kiselyov,
A.Kochoyan,
O.Kristensen,
J.S.Kastrup,
V.Berezin,
E.Bock,
and
M.Gajhede
(2007).
Structure of rat acidic fibroblast growth factor at 1.4 A resolution.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
65-68.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Goetz,
A.Beenken,
O.A.Ibrahimi,
J.Kalinina,
S.K.Olsen,
A.V.Eliseenkova,
C.Xu,
T.A.Neubert,
F.Zhang,
R.J.Linhardt,
X.Yu,
K.E.White,
T.Inagaki,
S.A.Kliewer,
M.Yamamoto,
H.Kurosu,
Y.Ogawa,
M.Kuro-o,
B.Lanske,
M.S.Razzaque,
and
M.Mohammadi
(2007).
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
|
| |
Mol Cell Biol, 27,
3417-3428.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.J.Kamerzell,
S.B.Joshi,
D.McClean,
L.Peplinskie,
K.Toney,
D.Papac,
M.Li,
and
C.R.Middaugh
(2007).
Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.
|
| |
Protein Sci, 16,
1193-1203.
|
 |
|
|
|
|
 |
Y.Ogawa,
H.Kurosu,
M.Yamamoto,
A.Nandi,
K.P.Rosenblatt,
R.Goetz,
A.V.Eliseenkova,
M.Mohammadi,
and
M.Kuro-o
(2007).
BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
|
| |
Proc Natl Acad Sci U S A, 104,
7432-7437.
|
 |
|
|
|
|
 |
Z.Liu,
T.Ishiwata,
S.Zhou,
S.Maier,
D.Henne-Bruns,
M.Korc,
M.Bachem,
and
M.Kornmann
(2007).
Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells.
|
| |
Pancreas, 35,
147-157.
|
 |
|
|
|
|
 |
A.Winter,
A.M.Yusof,
E.Gao,
H.L.Yan,
S.H.Sun,
and
A.Hofmann
(2006).
Biochemical characterization of annexin B1 from Cysticercus cellulosae.
|
| |
FEBS J, 273,
3238-3247.
|
 |
|
|
|
|
 |
D.Li,
Q.Q.Wang,
G.P.Tang,
H.L.Huang,
F.P.Shen,
J.Z.Li,
and
H.Yu
(2006).
Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
|
| |
J Zhejiang Univ Sci B, 7,
906-911.
|
 |
|
|
|
|
 |
E.G.Farrow,
S.I.Davis,
S.D.Mooney,
P.Beighton,
L.Mascarenhas,
Y.R.Gutierrez,
P.Pitukcheewanont,
and
K.E.White
(2006).
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia.
|
| |
Am J Med Genet A, 140,
537-539.
|
 |
|
|
|
|
 |
E.Sanchez-Heras,
F.V.Howell,
G.Williams,
and
P.Doherty
(2006).
The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule.
|
| |
J Biol Chem, 281,
35208-35216.
|
 |
|
|
|
|
 |
L.Duchesne,
B.Tissot,
T.R.Rudd,
A.Dell,
and
D.G.Fernig
(2006).
N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding.
|
| |
J Biol Chem, 281,
27178-27189.
|
 |
|
|
|
|
 |
P.R.Macdonald,
P.Progias,
B.Ciani,
S.Patel,
U.Mayer,
M.O.Steinmetz,
and
R.A.Kammerer
(2006).
Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope.
|
| |
J Biol Chem, 281,
28408-28414.
|
 |
|
|
|
|
 |
P.Wei,
J.Zhan,
S.Liu,
D.Chang,
R.Haldankar,
K.Burkhardt,
J.Crouse,
J.Hui,
T.Juan,
J.Talvenheimo,
H.Kim,
L.Li,
T.Boone,
and
L.Borges
(2006).
Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor.
|
| |
Hybridoma (Larchmt), 25,
115-124.
|
 |
|
|
|
|
 |
R.Sasisekharan,
R.Raman,
and
V.Prabhakar
(2006).
Glycomics approach to structure-function relationships of glycosaminoglycans.
|
| |
Annu Rev Biomed Eng, 8,
181-231.
|
 |
|
|
|
|
 |
S.K.Olsen,
J.Y.Li,
C.Bromleigh,
A.V.Eliseenkova,
O.A.Ibrahimi,
Z.Lao,
F.Zhang,
R.J.Linhardt,
A.L.Joyner,
and
M.Mohammadi
(2006).
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
|
| |
Genes Dev, 20,
185-198.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.P.Eswarakumar,
F.Ozcan,
E.D.Lew,
J.H.Bae,
F.Tomé,
C.J.Booth,
D.J.Adams,
I.Lax,
and
J.Schlessinger
(2006).
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
|
| |
Proc Natl Acad Sci U S A, 103,
18603-18608.
|
 |
|
|
|
|
 |
V.V.Kiselyov,
A.Kochoyan,
F.M.Poulsen,
E.Bock,
and
V.Berezin
(2006).
Elucidation of the mechanism of the regulatory function of the Ig1 module of the fibroblast growth factor receptor 1.
|
| |
Protein Sci, 15,
2318-2322.
|
 |
|
|
|
|
 |
V.V.Kiselyov,
E.Bock,
V.Berezin,
and
F.M.Poulsen
(2006).
NMR structure of the first Ig module of mouse FGFR1.
|
| |
Protein Sci, 15,
1512-1515.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.J.Robinson,
N.J.Harmer,
S.J.Goodger,
T.L.Blundell,
and
J.T.Gallagher
(2005).
Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes.
|
| |
J Biol Chem, 280,
42274-42282.
|
 |
|
|
|
|
 |
F.Soulet,
K.Bailly,
S.Roga,
A.C.Lavigne,
F.Amalric,
and
G.Bouche
(2005).
Exogenously added fibroblast growth factor 2 (FGF-2) to NIH3T3 cells interacts with nuclear ribosomal S6 kinase 2 (RSK2) in a cell cycle-dependent manner.
|
| |
J Biol Chem, 280,
25604-25610.
|
 |
|
|
|
|
 |
G.G.Whitehead,
S.Makino,
C.L.Lien,
and
M.T.Keating
(2005).
fgf20 is essential for initiating zebrafish fin regeneration.
|
| |
Science, 310,
1957-1960.
|
 |
|
|
|
|
 |
O.A.Ibrahimi,
B.K.Yeh,
A.V.Eliseenkova,
F.Zhang,
S.K.Olsen,
M.Igarashi,
S.A.Aaronson,
R.J.Linhardt,
and
M.Mohammadi
(2005).
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
|
| |
Mol Cell Biol, 25,
671-684.
|
 |
|
|
|
|
 |
V.K.Dubey,
J.Lee,
and
M.Blaber
(2005).
Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.
|
| |
Protein Sci, 14,
2315-2323.
|
 |
|
|
|
|
 |
B.Kaur,
C.Tan,
D.J.Brat,
D.E.Post,
and
E.G.Van Meir
(2004).
Genetic and hypoxic regulation of angiogenesis in gliomas.
|
| |
J Neurooncol, 70,
229-243.
|
 |
|
|
|
|
 |
C.Dodé,
and
J.P.Hardelin
(2004).
Kallmann syndrome: fibroblast growth factor signaling insufficiency?
|
| |
J Mol Med, 82,
725-734.
|
 |
|
|
|
|
 |
K.Nakano,
Y.Okada,
K.Saito,
and
Y.Tanaka
(2004).
Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
|
| |
Arthritis Rheum, 50,
2450-2458.
|
 |
|
|
|
|
 |
K.Nogami,
H.Suzuki,
H.Habuchi,
N.Ishiguro,
H.Iwata,
and
K.Kimata
(2004).
Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds.
|
| |
J Biol Chem, 279,
8219-8229.
|
 |
|
|
|
|
 |
L.Volpon,
H.Lamthanh,
J.Barbier,
N.Gilles,
J.Molgó,
A.Ménez,
and
J.M.Lancelin
(2004).
NMR solution structures of delta-conotoxin EVIA from Conus ermineus that selectively acts on vertebrate neuronal Na+ channels.
|
| |
J Biol Chem, 279,
21356-21366.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Numao,
H.Fujii,
Y.Fukazawa,
N.Hanagata,
and
K.Tanaka
(2004).
Hydrophobic scale: a second parameter to elucidating various specific ligand-protein interactions.
|
| |
Chem Pharm Bull (Tokyo), 52,
377-379.
|
 |
|
|
|
|
 |
S.Ashikari-Hada,
H.Habuchi,
Y.Kariya,
N.Itoh,
A.H.Reddi,
and
K.Kimata
(2004).
Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
|
| |
J Biol Chem, 279,
12346-12354.
|
 |
|
|
|
|
 |
S.K.Olsen,
O.A.Ibrahimi,
A.Raucci,
F.Zhang,
A.V.Eliseenkova,
A.Yayon,
C.Basilico,
R.J.Linhardt,
J.Schlessinger,
and
M.Mohammadi
(2004).
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.
|
| |
Proc Natl Acad Sci U S A, 101,
935-940.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Wang,
X.Ai,
S.D.Freeman,
M.E.Pownall,
Q.Lu,
D.S.Kessler,
and
C.P.Emerson
(2004).
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.
|
| |
Proc Natl Acad Sci U S A, 101,
4833-4838.
|
 |
|
|
|
|
 |
A.Facchiano,
K.Russo,
A.M.Facchiano,
F.De Marchis,
F.Facchiano,
D.Ribatti,
M.S.Aguzzi,
and
M.C.Capogrossi
(2003).
Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.
|
| |
J Biol Chem, 278,
8751-8760.
|
 |
|
|
|
|
 |
B.K.Yeh,
M.Igarashi,
A.V.Eliseenkova,
A.N.Plotnikov,
I.Sher,
D.Ron,
S.A.Aaronson,
and
M.Mohammadi
(2003).
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
|
| |
Proc Natl Acad Sci U S A, 100,
2266-2271.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Ito,
Y.Saitoh,
Y.Fujita,
Y.Yamazaki,
T.Imamura,
S.Oka,
and
S.Suzuki
(2003).
Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5.
|
| |
J Cell Physiol, 197,
272-283.
|
 |
|
|
|
|
 |
Q.Shi,
and
D.Boettiger
(2003).
A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397.
|
| |
Mol Biol Cell, 14,
4306-4315.
|
 |
|
|
|
|
 |
S.K.Olsen,
M.Garbi,
N.Zampieri,
A.V.Eliseenkova,
D.M.Ornitz,
M.Goldfarb,
and
M.Mohammadi
(2003).
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
|
| |
J Biol Chem, 278,
34226-34236.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Coumoul,
and
C.X.Deng
(2003).
Roles of FGF receptors in mammalian development and congenital diseases.
|
| |
Birth Defects Res C Embryo Today, 69,
286-304.
|
 |
|
|
|
|
 |
Z.L.Wu,
L.Zhang,
T.Yabe,
B.Kuberan,
D.L.Beeler,
A.Love,
and
R.D.Rosenberg
(2003).
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
|
| |
J Biol Chem, 278,
17121-17129.
|
 |
|
|
|
|
 |
A.I.Arunkumar,
S.Srisailam,
T.K.Kumar,
K.M.Kathir,
Y.H.Chi,
H.M.Wang,
G.G.Chang,
I.Chiu,
and
C.Yu
(2002).
Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens.
|
| |
J Biol Chem, 277,
46424-46432.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.I.Arunkumar,
T.K.Kumar,
K.M.Kathir,
S.Srisailam,
H.M.Wang,
P.S.Leena,
Y.H.Chi,
H.C.Chen,
C.H.Wu,
R.T.Wu,
G.G.Chang,
I.M.Chiu,
and
C.Yu
(2002).
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.
|
| |
Protein Sci, 11,
1050-1061.
|
 |
|
|
|
|
 |
A.O.Wilkie,
S.J.Patey,
S.H.Kan,
A.M.van den Ouweland,
and
B.C.Hamel
(2002).
FGFs, their receptors, and human limb malformations: clinical and molecular correlations.
|
| |
Am J Med Genet, 112,
266-278.
|
 |
|
|
|
|
 |
B.K.Yeh,
A.V.Eliseenkova,
A.N.Plotnikov,
D.Green,
J.Pinnell,
T.Polat,
A.Gritli-Linde,
R.J.Linhardt,
and
M.Mohammadi
(2002).
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
|
| |
Mol Cell Biol, 22,
7184-7192.
|
 |
|
|
|
|
 |
B.M.Loo,
and
M.Salmivirta
(2002).
Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
|
| |
J Biol Chem, 277,
32616-32623.
|
 |
|
|
|
|
 |
J.D.Esko,
and
S.B.Selleck
(2002).
Order out of chaos: assembly of ligand binding sites in heparan sulfate.
|
| |
Annu Rev Biochem, 71,
435-471.
|
 |
|
|
|
|
 |
P.Aloy,
and
R.B.Russell
(2002).
Interrogating protein interaction networks through structural biology.
|
| |
Proc Natl Acad Sci U S A, 99,
5896-5901.
|
 |
|
|
|
|
 |
T.J.Wang,
C.B.Huang,
F.J.Tsai,
J.Y.Wu,
R.B.Lai,
and
M.Hsiao
(2002).
Mutation in the FGFR2 gene in a Taiwanese patient with Beare-Stevenson cutis gyrata syndrome.
|
| |
Clin Genet, 61,
218-221.
|
 |
|
|
|
|
 |
C.Z.Borland,
J.L.Schutzman,
and
M.J.Stern
(2001).
Fibroblast growth factor signaling in Caenorhabditis elegans.
|
| |
Bioessays, 23,
1120-1130.
|
 |
|
|
|
|
 |
D.M.Ornitz,
and
N.Itoh
(2001).
Fibroblast growth factors.
|
| |
Genome Biol, 2,
REVIEWS3005.
|
 |
|
|
|
|
 |
E.J.Williams,
G.Williams,
F.V.Howell,
S.D.Skaper,
F.S.Walsh,
and
P.Doherty
(2001).
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth.
|
| |
J Biol Chem, 276,
43879-43886.
|
 |
|
|
|
|
 |
H.J.Hecht,
R.Adar,
B.Hofmann,
O.Bogin,
H.Weich,
and
A.Yayon
(2001).
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
378-384.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.E.White,
G.Carn,
B.Lorenz-Depiereux,
A.Benet-Pages,
T.M.Strom,
and
M.J.Econs
(2001).
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.
|
| |
Kidney Int, 60,
2079-2086.
|
 |
|
|
|
|
 |
O.A.Ibrahimi,
A.V.Eliseenkova,
A.N.Plotnikov,
K.Yu,
D.M.Ornitz,
and
M.Mohammadi
(2001).
Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
|
| |
Proc Natl Acad Sci U S A, 98,
7182-7187.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Bellosta,
A.Iwahori,
A.N.Plotnikov,
A.V.Eliseenkova,
C.Basilico,
and
M.Mohammadi
(2001).
Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.
|
| |
Mol Cell Biol, 21,
5946-5957.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|